Inogen Inc financial data

Symbol
INGN on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
859 Ward Drive, Goleta, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 296 % -36%
Quick Ratio 33.9 % -38.3%
Debt-to-equity 58.8 % +64.6%
Return On Equity -45.4 % -41.9%
Return On Assets -28.6 % -21.2%
Operating Margin -30.3 % -3.34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.7M shares +2.26%
Common Stock, Shares, Outstanding 23.7M shares +2.26%
Entity Public Float 268M USD -13.7%
Common Stock, Value, Issued 24K USD +4.35%
Weighted Average Number of Shares Outstanding, Basic 23.6M shares +2.03%
Weighted Average Number of Shares Outstanding, Diluted 23.6M shares +2.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 327M USD -6.48%
Revenue from Contract with Customer, Excluding Assessed Tax 265M USD -8.05%
Cost of Revenue 188M USD -11.6%
Research and Development Expense 23.4M USD +16.1%
Selling and Marketing Expense 104M USD -11.4%
General and Administrative Expense 77.5M USD +56.5%
Operating Income (Loss) -99M USD +3.34%
Nonoperating Income (Expense) 6.31M USD -4.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -92.7M USD +3.25%
Income Tax Expense (Benefit) -289K USD -165%
Net Income (Loss) Attributable to Parent -92.4M USD +4%
Earnings Per Share, Basic -3.98 USD/shares +5.24%
Earnings Per Share, Diluted -3.98 USD/shares +5.24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 97.9M USD -41.6%
Accounts Receivable, after Allowance for Credit Loss, Current 36M USD -29.5%
Inventory, Net 24M USD -21.8%
Assets, Current 195M USD -27.6%
Property, Plant and Equipment, Net 47M USD -4.42%
Operating Lease, Right-of-Use Asset 20M USD -1.56%
Goodwill 9.76M USD -70.3%
Other Assets, Noncurrent 3.81M USD +37.1%
Assets 309M USD -17.5%
Accounts Payable, Current 15M USD +12%
Employee-related Liabilities, Current 13.7M USD +26.9%
Liabilities, Current 72.2M USD +21.6%
Contract with Customer, Liability, Noncurrent 7.07M USD -24.4%
Deferred Income Tax Liabilities, Net 8.07M USD
Operating Lease, Liability, Noncurrent 18.1M USD -0.83%
Liabilities 121M USD +21.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -138K USD -286%
Retained Earnings (Accumulated Deficit) -137M USD -207%
Stockholders' Equity Attributable to Parent 188M USD -31.7%
Liabilities and Equity 309M USD -17.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.75M USD +24.6%
Net Cash Provided by (Used in) Financing Activities 285K USD -49%
Net Cash Provided by (Used in) Investing Activities -13.4M USD +21.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 23.7M shares +2.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18M USD +21.1%
Deferred Tax Assets, Valuation Allowance 60M USD +43%
Deferred Tax Assets, Gross 71.5M USD +27.9%
Operating Lease, Liability 21.4M USD -2.02%
Payments to Acquire Property, Plant, and Equipment 1.31M USD +21.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -92.7M USD +3.66%
Lessee, Operating Lease, Liability, to be Paid 23.5M USD -0.53%
Property, Plant and Equipment, Gross 94.2M USD -7.74%
Operating Lease, Liability, Current 3.33M USD -8.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +66.7%
Deferred Income Tax Expense (Benefit) -201K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.02M USD +18.6%
Deferred Tax Assets, Operating Loss Carryforwards 41.2M USD +48.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.78M USD +17.4%
Operating Lease, Payments 1.12M USD +12.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.27M USD +28.9%
Share-based Payment Arrangement, Expense 4.95M USD -62.8%